New insights into an old disease: Advanced imaging in the diagnosis and management of gout

Postgraduate Medical Journal

Volumn 89, Issue 1048, 2013, Pages 87-93

  McQueen, Fiona Marion ^a   Reeves, Quentin ^b   Dalbeth, Nicola ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

URATE;

BONE EROSION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; GOUT; HUMAN; INFLAMMATION; METACARPOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PSORIATIC ARTHRITIS; RADIOGRAPHY; REVIEW; ULTRASOUND;

ANTI-INFLAMMATORY AGENTS; GOUT; GOUT SUPPRESSANTS; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84872902121     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2012-131000     Document Type: Review

References (64)

1. Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther 2006;8(Suppl 1):S1.
2. Mandell BF. Clinical manifestations of hyperuricemia and gout. Cleve Clin J Med 2008;75(Suppl 5):S5-8.
3. Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1312-24.
4. Winnard D, Wright C, Taylor WJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology 2012;51:901-9.
5. Merriman TR, Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint, Bone, Spine 2011;78:35-40.
6. Lindsay K, Gow P, Vanderpyl J, et al. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumat 2011;17:1-6.
7. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population. Arthritis Rheum 2011;63:3136-41.
8. Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther 2010;12:206.
9. Schlesinger N, Thiele RG. The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 2010;69:1907-12.
10. Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis 2007;66:1374-7.
11. Dalbeth N, Pool B, Gamble GD, et al. Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010;62:1549-56.
12. McQueen FM, Chhana A, Dalbeth N. Mechanisms of joint damage in gout: evidence from cellular and imaging studies. Nat Rev Rheumatol 2012;8:173-81.
13. De Miguel E, Puig JG, Castillo C, et al. Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study. Ann Rheum Dis 2012;71:157-8.
14. Terkeltaub RA, Furst DE, Bennett K, et al. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010;62:1060-8.
15. Schlesinger N, Mysler E, Lin HY, et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann Rheum Dis 2011;70:1264-71.
16. Stamp LK, O'Donnell JL, Zhang M, et al. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Arthritis Rheum 2011;63:412-21.
17. Becker MA, Schumacher HR, Espinoza LR, et al. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther 2010;12:R63.
18. McGill NW. Management of gout: beyond allopurinol. Int Med J 2010;40:545-53.
19. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1301-11.
20. Watt I, Middlemiss H. The radiology of gout. Review article. Clin Radiol 1975;26:27-36.
21. Monu JUV, Pope TL Jr. Gout: a clinical and radiologic review. Radiol Clin North Am 2004;42:169-84.
22. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
23. Barthelemy CR, Nakayama DA, Carrera GF, et al. Gouty arthritis: a prospective radiographic evaluation of sixty patients. Skeletal Radiol 1984;11:1-8.
24. Rettenbacher T, Ennemoser S, Weirich H, et al. Diagnostic imaging of gout: comparison of high-resolution US versus conventional X-ray. Eur Radiol 2008;18:621-30.
25. Levin MH, Lichtenstein L, Scott HW. Pathologic changes in gout; survey of eleven necropsied cases. Am J Pathol 1956;32:871-95.
26. Wright JT. Unusual manifestations of gout. Australas Radiol 1966;10:365-74.
27. Dalbeth N, Clark B, McQueen F, et al. Validation of a radiographic damage index in chronic gout. Arthritis Rheum 2007;57:1067-73.
28. Dalbeth N, Collis J, Gregory K, et al. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology 2007;46:1804-7.
29. Keen HI, Brown AK, Wakefield RJ, et al. MRI and musculoskeletal ultrasonography as diagnostic tools in early arthritis. Rheum Dis Clin North Am 2005;31:699-714.
30. Balint PV, Kane D, Hunter J, et al. Ultrasound guided versus conventional joint and soft tissue fluid aspiration in rheumatology practice: a pilot study. J Rheumatol 2002;29:2209-13.
31. Cunnington J, Marshall N, Hide G, et al. A randomized, double-blind, controlled study of ultrasound-guided corticosteroid injection into the joint of patients with inflammatory arthritis. Arthritis Rheum 2010;62:1862-9.
32. Carter JD, Kedar RP, Anderson SR, et al. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology 2009;48:1442-6.
33. de Avila Fernandes E, Kubota ES, Sandim GB, et al. Ultrasound features of tophi in chronic tophaceous gout. Skeletal Radiol 2011;40:309-15.
34. Filippucci E, Riveros MG, Georgescu D, et al. Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound study. Osteoarthritis Cartilage 2009;17:178-81.
35. Lai K, Chiu Y. Role of Ultrasonography in Diagnosing Gouty Arthritis. J Med Ultrasound 2011;19:7-13.
36. Perez-Ruiz F, Dalbeth N, Urresola A, et al. Imaging of gout: findings and utility. Arthritis Res Ther 2009;11(3):232.
37. Thiele RG. Role of ultrasound and other advanced imaging in the diagnosis and management of gout. Curr Rheumatol Rep 2011;13:146-53.
38. Schueller-Weidekamm C, Schueller G, Aringer M, et al. Impact of sonography in gouty arthritis: comparison with conventional radiography, clinical examination, and laboratory findings. Eur J Radiol 2007;62:437-43.
39. Palmer DG, Hogg N, Denholm I, et al. Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules. Rheumatol Int 1987;7:187-93.
40. Perez-Ruiz F, Martin I, Canteli B. Ultrasonographic measurement of tophi as an outcome measure for chronic gout. J Rheumatol 2007;34:1888-93.
41. Thiele RG, Schlesinger N. Diagnosis of gout by ultrasound. Rheumatology 2007;46:1116-21.
42. Howard R, Pillinger MH, Gyftopoulos S, et al. Reproducibility of Musculoskeletal Ultrasound for Determining Monosodium Urate Deposition: Concordance Between Readers. Arthritis Care Res 2011;63:1456-62.
43. Pineda C, Amezcua-Guerra LM, Solano C, et al. Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 2011;13:R4.
44. Neogi T. Asymptomatic hyperuricemia: perhaps not so benign? J Rheumatol 2008;35:734-7.
45. Wright SA, Filippucci E, McVeigh C, et al. High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study. Ann Rheum Dis 2007;66:859-64.
46. Wakefield RJ, Gibbon WW, Conaghan PG, et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. (see comment). Arthritis Rheum 2000;43:2762-70.
47. Naredo E, Möller I, Cruz A, et al. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum 2008;58:2248-56.
48. Gerster JC, Landry M, Duvoisin B, et al. Computed tomography of the knee joint as an indicator of intraarticular tophi in gout. Arthritis Rheum 1996;39:1406-9.
49. Dalbeth N, Clark B, Gregory K, et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis 2009;68:1290-5.
50. Dalbeth N, Clark B, Gregory K, et al. Computed tomography measurement of tophus volume: comparison with physical measurement. Arthritis Rheum 2007;57:461-5.
51. Dalbeth N, Doyle A, Boyer L, et al. Development of a computed tomography method of scoring bone erosion in patients with gout: validation and clinical implications. Rheumatology 2011;50:410-6.
52. Nicolaou S, Yong-Hing CJ, Galea-Soler S, et al. Dual-energy CT as a potential new diagnostic tool in the management of gout in the acute setting. AJR Am J Roentgenol 2010;194:1072-8.
53. Dalbeth N, Aati O, Gao A, et al. Assessment of tophus size: a comparison between physical measurement methods and dual-energy computed tomography scanning. J Clin Rheumatol 2012;18:23-7.
54. Rech J, Lell M, Wacker JS, et al. Detection of periarticular urate deposits with dual energy computed tomography in patients with acute gouty arthritis. Arthritis Rheum 2011;63(Suppl 10):209.
55. Glazebrook KN, Guimarães LS, Murthy NS, et al. Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation. Radiology 2011;261:516-24.
56. Choi H, Burns LC, Shojania K, et al. Dual energy CT in gout: a prospective validation study. Ann Rheum Dis 2012;71:1466-71.
57. McQueen FM, Doyle AJ, Reeves Q, et al. DECT urate deposits: now you see them now you don't. Ann Rheum Dis. Published Online First: 28 Sept 2012. doi:10.1136/annrheumdis-2012-202452.
58. Bongartz T, Glazebrook KN, Kavros SJ, et al. Diagnosis of gout using dual-energy computed tomography: an accuracy and diagnostic yield study. Arthritis Rheum 2011;63(Suppl 10):1617.
59. Poh YJ, Dalbeth N, Doyle A, et al. Magnetic resonance imaging bone edema is not a major feature of gout unless there is concomitant osteomyelitis: 10-year findings from a high-prevalence population. J Rheumatol 2011;38:2475-81.
60. Dalbeth N, Smith T, Gray S, et al. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis 2009;68:279-82.
61. McQueen FM, Benton N, Perry D, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1814-27.
62. Gentili A. The advanced imaging of gouty tophi. Curr Rheumatol Rep 2006;8:231-5.
63. McQueen FM, Doyle A, Dalbeth N. Imaging in gout: what can we learn from MRI, CT, DECT and US. Arthritis Res Ther 2011;13.
64. Ko KH, Hsu YC, Lee HS, et al. Tophaceous gout of the knee: revisiting MRI patterns in 30 patients. J Clin Rheumatol 2010;16:209-14.